Replies to post #401982 on Anavex Life Sciences Corp (AVXL)

[LBSR TO DA MOON]

Back in early December 2022, Cantor Fitzgerald's Charles Duncan downgraded AVXL from Overweight to Neutral and lowered his price target down from $16.00 to $11.00. I wonder if he will be making any revisions in the near future...